Biofrontera Revenue Per Share from 2010 to 2025

BFRIW Stock  USD 0.1  0.02  28.57%   
Biofrontera Warrants Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share is likely to outpace its year average in 2025. Revenue Per Share is the amount of revenue generated by Biofrontera Warrants per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
25.34
Current Value
33.65
Quarterly Volatility
7.91002465
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 202.9 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.14, Dividend Yield of 0.0 or PTB Ratio of 0.98. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Biofrontera Warrants over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Biofrontera Warrants' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 8.49710 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Biofrontera Revenue Per Share Regression Statistics

Arithmetic Mean37.51
Geometric Mean36.61
Coefficient Of Variation21.09
Mean Deviation7.03
Median43.13
Standard Deviation7.91
Sample Variance62.57
Range21.0979
R-Value(0.80)
Mean Square Error23.79
R-Squared0.65
Significance0.0002
Slope(1.33)
Total Sum of Squares938.53

Biofrontera Revenue Per Share History

2025 33.65
2024 25.34
2023 22.03
2022 27.13
2021 28.18
2020 32.5

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 25.34  33.65 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.